NCT02209805View on ClinicalTrials.gov

Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered to Healthy Human Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

March 31, 2001

Conditions
Healthy
Interventions
DRUG

BIRB 796 BS, low dose

DRUG

BIRB 796 BS, high dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02209805 - Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered to Healthy Human Subjects | Biotech Hunter | Biotech Hunter